Imagine if data could power smarter care for every person with cancer.
Vineeta Agarwalanamed it in 4 interviews“Still a practicing physician today, Vineeta Agarwala describes her educational background and early career, including experiences at the Broad Institute, Flatiron Health, and GV (Google Ventures).” — Episode 23: a16z's Vineeta Agarwala (BioVenture VoiCes with Chris Garabedian, 2025)
Josh Kopelmannamed it in 2 interviews“Josh Kopelman , Founder and Partner at First Round Capital , a seed-stage venture firm that has invested in some of the biggest names, including Uber, Square and Flatiron Health.” — Josh Kopelman, Founder of First Round Capital and investor in Uber, Square & Flatiron, on living in Philly, investing in NY and scaling teams beyond Silicon Valley. (Seed to Scale, 2019)
Anthony Philippakisnamed it in 1 interview“Amy Abernethy is an oncologist, specialist in palliative care medicine, researcher, previous Professor of Medicine at Duke University School of Medicine, previous Scientific and Medical Chief Officer of Flatiron Health, and previous Principal Deputy Commissioner of the FDA.” — Dr. Amy Abernethy on Closing the Gap Between Clinical Practice and Clinical Research (Theory and Practice, 2021)
Daniel Burkanamed it in 1 interview“He went on to become a design partner at Google Ventures for five years and worked with a huge variety of companies like Flatiron Health, Zipline, Farmers Business Network and Blue Bottle Coffee.” — Designing Solutions in Global Health | Daniel Burka (Design Lab with Bon Ku, 2021)
Krishna Yeshwantnamed it in 1 interview“Most of his investments are at the intersection of life sciences and data sciences, like Flatiron Health , Foundation Medicine , EQRx , and Imagen .” — Dr. Krishna Yeshwant on Exploring the Intersection of Technology and Life Sciences (Theory and Practice, 2021)| John Zeratsky, Character Capital GP on Startup Sprints & Design DNA | John Zeratsky | Venture with Grace | 2025-08-05 | John Zeratsky (JZ) is a Co-Founder and General Partner at Character Capital, where he supports startup founders with capital and sprints. He’s a bestselling author of Sprint and Make Time, and has reached millions with articles in The Wall Street Journal, TIME, Harvard Business Review, Wired, Fast Company, and other outlets. JZ is a former Design Partner at GV (Google Ventures), where he developed the Sprint method and supported many of GV’s most successful investments, including Slack, One Medical Group, Flatiron Health, Blue Bottle Coffee, and Gusto. Previously, JZ was a design leader for YouTube, Google Ads, and FeedBurner, which was acquired by Google in 2007.Topics: How VCs can use sprint principles to make faster, better investment decisions Common traits across successful investments like Slack, One Medical, and Blue Bottle Industries where AI will create the most venture-scale opportunities #VentureCapital #AI #StartupInvesting #DesignSprint #ProductMarketFit | |
| Episode 23: a16z's Vineeta Agarwala | Vineeta Agarwala | BioVenture VoiCes with Chris Garabedian | 2025-07-28 | Still a practicing physician today, Vineeta Agarwala describes her educational background and early career, including experiences at the Broad Institute, Flatiron Health, and GV (Google Ventures). She talks about a16z's investment philosophy of "providing more than just a check," and a recent $500M fund partnered with Lilly. | |
| Vineeta Agarwala - Venture Capital, a16z, and the MaML space | Vineeta Agarwala | The MaML Podcast - Medicine & Machine Learning | 2022-06-23 | Dr. Vineeta Agarwala is a general partner at a16z, physician, adjunct clinical professor at Stanford, previously at Google Ventures, Flatiron Health, having received her MD/PhD at Harvard Medical School and the Broad Institute. Many thanks to Ashlea Kosikowski from 1AB Media for making this episode happen! Follow us on twitter: @TheMaMLPodcast Host: David JH Wu @davidjhwu Producer: Aaron Schumacher @a_schu95 Design: Saurin Kantesaria | |
| Ep. 228 How I Raised It With John Zeratsky Of Venture Fund Character | Eli Blee-Goldman | How I Raised It - The podcast where we interview startup founders who raised capital. | 2022-03-18 | Produced by Foundersuite (www.foundersuite.com), "How I Raised It" goes behind the scenes with startup founders and investors who have raised capital. This episode is with John Zeratsky of Character, a Milwaukee based venture fund with an investment strategy focused on Product Design (www.character.vc). In this episode, John shares his 5-day design sprint process, what he's looking to invest in, tips for qualifying and pitching LPs, and more. Character has raised $30 million for its inaugural fund. Previously, John and his co-founder Jake Knapp worked at Google Ventures, where they used their product design skills to help companies like Slack, Blue Bottle, and Flatiron Health through hundreds of 5-day design sprints. They are joined by a third partner, Eli Blee-Goldman. How I Raised It is produced by Foundersuite, makers of software to raise capital and manage investor relations. Foundersuite's customers have raised over $3 Billion since 2016. Create a free account at www.foundersuite.com. | |
| Designing Solutions in Global Health | Daniel Burka | Daniel Burka | Design Lab with Bon Ku | 2021-09-09 | 48 min | Daniel Burka is a product manager and designer who focuses on solving complex global health problems in simple ways. He is the director of product and design at the not-for-profit Resolve to Save Lives, where he spends the majority of my time on the open source project, Simple.org. Simple is used by thousands of hospitals in India, Bangladesh, and Ethiopia to manage over 950,000 patients with hypertension. In his prior life Daniel and his business partner Kevin Rose started an incubator company called Milk which we sold to Google a year later. He went on to become a design partner at Google Ventures for five years and worked with a huge variety of companies like Flatiron Health, Zipline, Farmers Business Network and Blue Bottle Coffee. In 2021, Daniel also started the open source Healthicons.org project to provide free icons to healthcare projects around the world. Bon and Daniel talk about reducing mortality in non-communicable diseases in India, the journey from Silicon Valley to Global Health and why everyone needs a design mindset. |
| Leveraging Your Superpowers with Dr. Vineeta Agarwala (Andreessen Horowitz) | Vineeta Agarwala | Spotlight on Women in Health Ventures | 2021-08-11 | Vineeta Agarwala, MD, PhD, is a General Partner at Andreessen Horowitz (a16z) and adjunct clinical professor in the Division of Primary Care and Population Health at Stanford. She previously worked as a management consultant at McKinsey and as a Director of Product Management at Flatiron Health. At a16z, she works with companies seeking to improve how drug development and patient care delivery is done. We discuss with Dr. Agarwala the importance of adopting a “continuous learner” mindset, how to make the jump from academia to entrepreneurship, and trends in biotech and health tech, including a DoorDash-infrastructure for healthcare delivery. | |
| Dr. Amy Abernethy on Closing the Gap Between Clinical Practice and Clinical Research | Anthony Philippakis | Theory and Practice | 2021-05-27 | Physicians make very big decisions in people's lives. Whether or not to put in a heart valve, whether to do a stent or surgery, what chemotherapy to dose. We often make these big decisions with very little data for decision support. This has to change. As we discuss in this episode, the future of medicine will involve advanced machine learning to improve clinical decision making, and better ways to match patients to personalized therapies. Dr. Amy Abernethy is an oncologist, specialist in palliative care medicine, researcher, previous Professor of Medicine at Duke University School of Medicine, previous Scientific and Medical Chief Officer of Flatiron Health, and previous Principal Deputy Commissioner of the FDA. Theory and Practice is a presentation of GV and Google AI . Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scientist with Google AI), Theory and Practice opens the doors to the cutting edge of biology and computer science through conversations with leaders in the field. | |
| Dr. Krishna Yeshwant on Exploring the Intersection of Technology and Life Sciences | Krishna Yeshwant | Theory and Practice | 2021-05-06 | Krishna Yeshwant is Managing Partner at GV , and a practicing physician at Brigham and Women’s Hospital in Boston. Krishna embodies this mix of being both an intellectual and a business person. Most of his investments are at the intersection of life sciences and data sciences, like Flatiron Health , Foundation Medicine , EQRx , and Imagen . He's interested in finding companies at that interface. You'll hear him talk about starting his first company, making the mistake of hiring his friends, and the bumps and bruises of learning. Theory and Practice is a presentation of GV and Google AI . Hosted by Anthony Philippakis (Venture Partner at GV) and Alex Wiltschko (Staff Research Scientist with Google AI), Theory and Practice opens the doors to the cutting edge of biology and computer science through conversations with leaders in the field. | |
| Virtual Oncology | Vineeta Agarwala | The a16z Show | 2020-04-10 | with @vintweeta @pbcancerdoc @sumitshahmd @omnivorousread Coronavirus is now disrupting the entire health care system, not just because of the burden of dealing with the actual disease itself, but because of everything else that's had to grind to a halt. One of the areas where we really worry about things coming to a total stop like that is, of course, cancer treatment, which can often feel like a race against the clock even under the best conditions. In this episode, Dr. Bobby Green, MD (Community Oncologist and Chief Medical Officer, Flatiron Health) and Dr. Sumit Shah (Oncologist and Head of Digital Health, Stanford Cancer Center) join a16z's Vineeta Agarwala (physician and general partner) and Hanne Tidnam to talk about what is happening to oncology during the outbreak—how treatment is affected; what kind of clinical decisions oncologists and patients are having to make, and how they're making them; the tech tools that specialists are using, and how they could improve; and what happens to oncology as a whole when it's forced to go virtual. | |
| Josh Kopelman, Founder of First Round Capital and investor in Uber, Square & Flatiron, on living in Philly, investing in NY and scaling teams beyond Silicon Valley. | Chris Fralic, Josh Kopelman | Seed to Scale | 2019-07-23 | Josh Kopelman , Founder and Partner at First Round Capital , a seed-stage venture firm that has invested in some of the biggest names, including Uber, Square and Flatiron Health. First Round aims to help early-stage companies build a strong product-market fit and offers some of the industry’s first and best tools from their custom-built software to sharing their deep industry insight with their publication First Round Review . In this episode, Josh speaks with Eniac Co-founding Partner Nihal Mehta on his journey from being one of the first students at Penn to get an email address to how he leveraged his early experience on the Internet to founding his first three companies - Infonautics, Half.com, and TurnTide. Josh then seized the opportunity to start First Round with Chris Fralic and Rob Hayes when the cost to start a company was decreasing, but the average venture firm tripled in size. Josh speaks to his advantage of living in Philadelphia, why they are placing big bets in New York and his perspective why it has never been easier to build a company outside of Silicon Valley. He also addresses scaling teams and the regional talent gap. He speaks to why First Round operates like a startup, continuing to improve and find new products that better serve their founders and community. He also shares why their fund size has remained consistent and how they view fund model vs fund size. Josh also shares why they left Twitter, DropBox, and Zynga on the table. | |
| 20VC: First Round's Josh Kopelman on Why Price Is Both An Art and A Science, Why Ownership Must Be Built on First Check and The Negative Consequences of Attribution in Venture | Josh Kopelman | The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch | 2019-01-28 | Josh Kopelman is Founder & Partner @ First Round, one of the world's leading seed funds with a portfolio including the likes of Uber, Warby Parker, Flatiron Health, Square, HotelTonight, GOAT and more incredible companies. As for Josh, he founded First Round in 2004 to reinvent seed stage investing. Since he has invested in over 200 startups and been ranked 4th in Forbes Midas List and named one of the top ten 'angel investors' in the US by Newsweek magazine. Josh has previously sat on the boards of Flatiron Health, Clover Health, AppNexus and more. In Today's Episode You Will Learn: 1.) How Josh made his way into the wonderful world of venture from angel investing and what the inspiration behind the founding of First Round was? 2.) How does Josh think about price sensitivity today? What were his learnings from being priced out of the seed round for Twitter and Dropbox? How has Josh seen his relationship to price change over time? How did witnessing the boom and bust both as operator and investor affect his investing mentality today? 3.) How does Josh and First Round think about reserve allocation? How has their thinking changed and evolved over time? Does Josh believe that ownership is fundamentally built on first check? What does the investment decision-making process look like for reserves? In terms of allocation, how does Josh think about time allocation across portfolio? Spend it with the winners, they return the fund or the strugglers and save cents on the dollar? 4.) |
VJohn Zeratsky, Character Capital GP on Startup Sprints & Design DNAVenture with Grace · 2025-08-05
DDesigning Solutions in Global Health | Daniel BurkaDesign Lab with Bon Ku · 2021-09-09